These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1113917

  • 1. [Medical treatment of obliterating peripheral arteriopathies, especially arteriosclerosis].
    Scaffidi V.
    Minerva Med; 1975 Jan 13; 66(2):55-65. PubMed ID: 1113917
    [Abstract] [Full Text] [Related]

  • 2. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A, Moia R.
    Minerva Med; 1978 Apr 21; 69(19):1287-93. PubMed ID: 662155
    [Abstract] [Full Text] [Related]

  • 3. Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.
    Ost CR, Sténson S.
    Scand J Clin Lab Invest Suppl; 1967 Apr 21; 99():241-5. PubMed ID: 6056927
    [No Abstract] [Full Text] [Related]

  • 4. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E, Azzolini A, De Cristofaro A, Papacharalambus D.
    Minerva Cardioangiol; 1972 Apr 21; 20(7):369-89. PubMed ID: 5050745
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical trial of a long-acting vasodilator agent in chronic peripheral obliterating arteriopathy of a sclerotic nature].
    Gemma GB, Ghezzi P, Cavaliere P.
    Minerva Cardioangiol; 1969 May 21; 17(5):324-32. PubMed ID: 5785730
    [No Abstract] [Full Text] [Related]

  • 6. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
    Hansteen V, Lorentsen E.
    Acta Med Scand Suppl; 1974 May 21; 556():3-62. PubMed ID: 4366049
    [No Abstract] [Full Text] [Related]

  • 7. [Chorionic gonadotropin (HCG) in the therapy of chronic peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by arteriosclerosis].
    Bonandrini L, Mantellini E, Colombo P, Seghezzi R, Lombardo F.
    Minerva Chir; 1970 Mar 15; 25(5):368-83. PubMed ID: 5438397
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of peripheral obliterating arteriopathies with intra-arterial perfusions of dextran of low molecular weight and vasodilator agents].
    Buccellato C, Di Lorenzo GD.
    Minerva Chir; 1967 Jun 15; 22(11):692-5. PubMed ID: 6050666
    [No Abstract] [Full Text] [Related]

  • 9. [Short-term heparin therapy in obliterating arteriopathies of the lower limbs].
    Arrigo F, Coglitore S, Giannetto M, Bramanti O, Barbera C, Consolo F.
    Boll Soc Ital Cardiol; 1977 Jun 15; 22(3):273-82. PubMed ID: 617274
    [No Abstract] [Full Text] [Related]

  • 10. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A, Bory M, Poggi L, Audier M.
    Rev Atheroscler (Paris); 1968 Jun 15; 10(2):3-8. PubMed ID: 5759950
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical, oscillographic and plethysmographic comparison before and after medical and surgical treatment of subjects with peripheral obliterating arteriopathy].
    Tardito E, Grassi T.
    Minerva Med; 1971 May 16; 62(39):1971-80. PubMed ID: 5579735
    [No Abstract] [Full Text] [Related]

  • 13. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L.
    Med Pregl; 1975 May 16; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V, Lorentsen E.
    Tidsskr Nor Laegeforen; 1971 Aug 30; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract] [Full Text] [Related]

  • 16. [On some aspects of therapy of chronic peripheral obliterating arteriopathies (C.P.O.A.) on arteriosclerotic nature].
    Seghezzi R, Borri P, Pedroni G.
    Minerva Med; 1968 Dec 12; 59(99):5458-65. PubMed ID: 5718833
    [No Abstract] [Full Text] [Related]

  • 17. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L, Macchioni P, Di Leo M, Nosenzo C.
    Minerva Cardioangiol; 1972 Sep 12; 20(9):484-96. PubMed ID: 5071470
    [No Abstract] [Full Text] [Related]

  • 18. [Use of vasoprostan in the treatment of obliterating atherosclerosis of the lower limbs].
    Sukharev II, Guch AA.
    Klin Khir (1962); 1994 Sep 12; (7):22-4. PubMed ID: 7823491
    [Abstract] [Full Text] [Related]

  • 19. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H.
    Med Monatsschr; 1969 Dec 12; 23(12):558-61. PubMed ID: 5387170
    [No Abstract] [Full Text] [Related]

  • 20. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R, Pedroni G, Borri P.
    Chir Ital; 1967 Dec 12; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.